Journal
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
Volume 30, Issue 2, Pages 107-112Publisher
FRONTLINE MEDICAL COMMUNICATIONS
DOI: 10.1016/j.sder.2011.05.003
Keywords
-
Categories
Ask authors/readers for more resources
Itch represents a common and significant source of morbidity in the oncological setting. Itch sometimes can be associated with an underlying malignancy, most commonly leukemia or lymphoma. Alternatively, itch may present secondary to malignant invasion causing hepatic or renal dysfunction. Finally, itch may be related to therapeutic regimens for the underlying malignancy. This article seeks to review the clinical scenarios in which itch affects the oncological patient, to briefly present the latest understanding of the molecular and cellular mechanisms of malignancy-related itch, and to review currently available therapeutic options. Semin Cutan Med Surg 30:107-112 (C) 2011 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available